𝔖 Bobbio Scriptorium

✦ LIBER ✦

Evaluation of Thompson's buried dermal flap operation for lymphoedema of the limbs: A clinical and radioisotopic study

✍ Scribed by C.P. Sawhney

Book ID: 114006964
Publisher: Elsevier Science
Year: 1974
Tongue: English
Weight: 386 KB
Volume: 27
Category: Article
ISSN: 0007-1226
DOI: 10.1016/s0007-1226(74)90089-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the Efficacy of the Acellu

Evaluation of the Efficacy of the Acellular Dermal Matrix Allograft with Partial Thickness Flap in the Elimination of Gingival Melanin Pigmentation. A Comparative Clinical Study with 12 Months of Follow-Up

✍ Ana E. f. Pontes; Carla C. Pontes; Sérgio l. s. Souza; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

COMMENTARY : evaluation of the efficacy

COMMENTARY : evaluation of the efficacy of the acellular dermal matrix allograft with partial thickness flap in the elimination of gingival melanin pigmentation: a comparative clinical study with 12 months of follow-up

✍ Edward P. Allen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Clinical utility and interobserver agree

Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study

✍ Giacchino, Maria; Bansal, Ajay; Kim, Raymond E.; Singh, Vikas; Hall, Sandy B.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 959 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB